Beijing Hotgen Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	-	270.15	276.11	523.49	1,161
Short-Term Investments	-	601.14	50	50.95	-
Trading Asset Securities	-	201.51	280.02	888.68	927.45
Cash & Short-Term Investments	1,093	1,073	606.13	1,463	2,089
Cash Growth	1.90%	76.99%	-58.57%	-29.94%	445.84%
Accounts Receivable	-	92.49	28.59	102.04	38.21
Other Receivables	-	24.13	28.93	17.01	47.36
Receivables	-	116.62	57.52	119.06	85.57
Inventory	-	83.45	137.21	154.25	258.62
Prepaid Expenses	-	-	0.15	2.6	-
Other Current Assets	-	19.55	38.9	59.24	84.98
Total Current Assets	-	1,292	839.91	1,798	2,518
Property, Plant & Equipment	-	1,074	1,193	867.94	562.12
Long-Term Investments	-	826.04	1,418	1,038	441.6
Other Intangible Assets	-	52.12	55.07	56.55	57.33
Long-Term Deferred Tax Assets	-	26.64	34.4	38.8	15.95
Long-Term Deferred Charges	-	25.55	24.3	23.2	22.32
Other Long-Term Assets	-	29.3	6.76	76.21	27.85
Total Assets	-	3,326	3,572	3,899	3,645
Accounts Payable	-	46.12	44.72	151.52	141.27
Accrued Expenses	-	30.23	25.55	177.68	167.53
Current Portion of Leases	-	0.12	7.49	27.95	13
Current Income Taxes Payable	-	1.06	1.15	1.13	120.24
Current Unearned Revenue	-	16.7	28.08	56.98	267.05
Other Current Liabilities	-	141.66	81.05	96.06	25.08
Total Current Liabilities	-	235.89	188.04	511.31	734.16
Long-Term Leases	-	0.12	7.76	14.18	22.98
Long-Term Unearned Revenue	-	15.75	9.77	10.77	9.47
Long-Term Deferred Tax Liabilities	-	-	-	9.32	4.41
Total Liabilities	-	251.77	205.57	545.59	771.01
Common Stock	-	92.47	92.27	92.05	62.2
Additional Paid-In Capital	-	321.41	444.04	435.31	458.31
Retained Earnings	-	2,786	2,994	2,958	2,323
Treasury Stock	-	-133.89	-166.48	-150.04	-
Comprehensive Income & Other	-	9.96	4.32	-0.03	-0.3
Total Common Equity	2,933	3,076	3,368	3,335	2,844
Minority Interest	-	-1.43	-2.12	18.46	30.31
Shareholders' Equity	2,930	3,074	3,366	3,354	2,874
Total Liabilities & Equity	-	3,326	3,572	3,899	3,645
Total Debt	50.11	0.24	15.26	42.13	35.98
Net Cash (Debt)	1,043	1,073	590.87	1,421	2,053
Net Cash Growth	-2.75%	81.52%	-58.42%	-30.77%	436.43%
Net Cash Per Share	11.10	11.61	6.69	15.46	22.30
Filing Date Shares Outstanding	110.17	89.58	89.41	89.53	92.05
Total Common Shares Outstanding	88.83	89.58	89.41	89.53	92.05
Working Capital	-	1,057	651.88	1,287	1,784
Book Value Per Share	33.01	34.33	37.67	37.25	30.89
Tangible Book Value	2,883	3,023	3,313	3,279	2,786
Tangible Book Value Per Share	32.46	33.75	37.06	36.62	30.27
Buildings	-	703.6	704.79	174.55	162.16
Machinery	-	567.73	575.66	399.88	317.94
Construction In Progress	-	5.62	48.18	374.44	121.71

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.